Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability.
about
Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Anti-tumor efficacy of a novel ...... d MYC-dependent vulnerability.
@en
Anti-tumor efficacy of a novel ...... d MYC-dependent vulnerability.
@nl
type
label
Anti-tumor efficacy of a novel ...... d MYC-dependent vulnerability.
@en
Anti-tumor efficacy of a novel ...... d MYC-dependent vulnerability.
@nl
prefLabel
Anti-tumor efficacy of a novel ...... d MYC-dependent vulnerability.
@en
Anti-tumor efficacy of a novel ...... d MYC-dependent vulnerability.
@nl
P2093
P2860
P356
P1476
Anti-tumor efficacy of a novel ...... nd MYC-dependent vulnerability
@en
P2093
Gyorgy Snell
Hironobu Maezaki
Kazuho Nishimura
Kenichi Iwai
Kozo Hayashi
Maki Miyamoto
Masahiro Yaguchi
Michael G Klein
Mika Teratani
Misa Iwatani
P2860
P356
10.15252/EMMM.201708289
P577
2018-06-01T00:00:00Z